RT Journal Article
SR Electronic
T1 Beyond Volume: Unraveling the Genetics of Human Brain Geometry
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.25.24309376
DO 10.1101/2024.06.25.24309376
A1 Primus, Sabrina A.
A1 Hoffstaedter, Felix
A1 Raimondo, Federico
A1 Eickhoff, Simon B.
A1 Winkelmann, Juliane
A1 Oexle, Konrad
A1 Patil, Kaustubh R.
YR 2024
UL http://medrxiv.org/content/early/2024/06/25/2024.06.25.24309376.abstract
AB Brain geometry impacts brain function. A quantitative encoding of form is provided by the Laplace-Beltrami operator’s spectrum of eigenvalues (LBS). We examined LBS genetics of 22 subcortical brain structures including cerebellum in 19,862 healthy White-British UK Biobank participants by multivariate GWAS (MOSTest) on the first 49 eigenvalues each. Controlling for surface and volume, we identified 80 unique variants (p<1/22*5E-8) influencing the shapes of one or several structures, with the highest yield (37 variants) for brain stem. The previously known influence of several of these loci on basic morphology, such as volume, is thus shown to also influence complex shape. Known associations of observed loci with blood pressure, neurodegeneration, alcohol consumption, and mental disorders hint at preclinical stages of these conditions potentially mediating the genetic effect on brain morphology. Significant correlations between LBS of several brain structures and the polygenic risks of hypertension, ischemic stroke and schizophrenia evince brain shapes as early biomarkers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Helmholtz Imaging grants (NimRLS, ZT-I-PF-4-010 and BrainShapes, ZT-I-PF-4-062).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research was conducted using the UK Biobank resource under application number 41655. UK Biobank has approval from the North West Multi-centre Research Ethics Committee (MREC) as a Research Tissue Bank (RTB) approval.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe primary data used in this study is from the UK Biobank. These data can be provided by UK Biobank pending scientific review and a completed material transfer agreement. Requests for the data should be submitted to the UK Biobank: www.ukbiobank.ac.uk. Specific UK Biobank data field codes are given in Materials and Methods. Other publicly available data sources and applications are cited in Materials and Methods. We will make our summary statistics available online within the GWAS catalog: https://ebi.ac.uk/gwas/. We will further publish the FUMA results within the FUMA database. Until then summary statistics and FUMA results can be obtained upon reasonable request to the authors.